Company Information

  

Address: 2910 SEVENTH ST  
City: BERKELEY 
State: CA 
Zip Code: 94710 
Telephone: 510-644-1170 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

XOMA Corporation ("XOMA"), a Delaware corporation, has an established history of discovering and developing innovative therapeutics derived from its unique platform of antibody technologies. We typically have sought to license these therapeutic assets to our licensees who take on the responsibilities of later stage development, approval and commercialization. In addition, we have licensed our antibody technologies on a non-exclusive basis to other companies who desire to access this platform for their own discovery efforts. We are evolving our strategy to be focused on developing or acquiring revenue-generating assets and coupling them with a lean corporate infrastructure. Our goal is to create a sustainably profitable business and generate meaningful value for our stockholders.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-7.18NAN/E
03/2017-9.86NAN/E
12/2016-8.89NAN/E
09/2016-31.40NAN/E
06/20168.00NA1.38

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.05Total Liab/Total Assets2.65
Net Inc/Total Assets-1.87Total Liab/Inv Cap-19.82
Net Inc/Inv Cap13.98Total Liab/Comm Equity0.07
Pretax Inc/Net Sales-9.62Interest Coverage Ratio-12.57
Net Inc/Net Sales-9.62Curr Debt/EquityNA
Cash Flow/Net Sales-6.05LTD/Equity-0.54
SG&A/NetSales3.29Total Debt/Equity-0.54
Asset Utilization   Liquidity  
Net Receivables Turnover2.40Quick Ratio0.84
Inventory TurnoverNACurrent Ratio0.84
Inventory Day SalesNANet Rec/Curr Assets0.02
Net Sales/Work Cap-1.04Inv/Curr AssetsNA
Net Sales/PP&E5.37  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 10.89 0.26 0.52 0.64
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 5.20 5.17 5.18 4.05
Operating Income 1.31 -10.92 -17.46 -12.09
Interest Exp 0.30 0.61 0.96 0.98
Pretax Income 0.29 -10.20 -17.48 -12.53
Other Income -0.73 0.81 0.93 0.55
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 0.29 -10.72 -17.48 -12.53

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 12.47 20.05 25.74 20.62
Receivables - Total 10.63 1.34 0.57 0.76
Inventories - Total NA NA NA NA
Total Current Assets 23.43 21.65 27.16 22.63
Net Property, Plant & Equipment 0.23 0.40 1.04 1.40
Total Assets 24.15 22.53 28.68 24.69
Liabilities        
Accounts Payable 5.70 6.53 10.16 9.65
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 21.68 22.25 32.51 23.01
Long-Term Debt 14.32 14.09 25.31 32.76
Total Liabilities 53.26 53.74 75.89 55.88
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.06 0.06 0.05 0.90
Retained Earnings -1,204.08 -1,204.37 -1,193.61 -1,176.13
Treasury Stock NA NA NA NA
Total Stockholders' Equity -29.12 -31.21 -47.21 -31.19
Total Liabilities and Stockholders' Equity 24.15 22.53 28.68 24.69

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -8.41 -14.35 7.00 -12.05
Net Cash Provided by Investing Activities 0.80 0.81 -0.02 0.62
Net Cash Provided by Financing Activities 0.02 7.87 -1.85 -1.81

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201233.78-71.06--
12/201335.45-124.06--
12/201418.87-38.30--
12/201555.45-20.61--
12/20165.56-53.53-8.89
Growth Rates-36.29----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17372,49832.88




Report Date : 10/9/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.